Added to YB: 2025-09-17
Pitch date: 2025-09-14
DXCM [neutral]
DexCom, Inc.
-12.4%
current return
Author Info
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$76.44
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
3 Healthcare Stocks on My Radar - DexCom, Inc.
DXCM (quick overview): CGM leader w/ 95% sensor revenue from razor-blade model, high retention vs competitors. Bear case: Abbott/Medtronic price pressure, GLP-1 drugs may reduce T2 diabetes CGM need. Bull case: low penetration in 100M+ US T2/prediabetic market, intl growth, Stelo OTC expansion.
Read full article (2 min)